Skip to main content

Table 2 Factors Influencing Polypharmacy (Simple Correlations)

From: Feedback of patient survey on medication improves the management of polypharmacy: a pilot trial

 

Polypharmacy group

(n = 138)

Non polypharmacy group

(n = 269)

p-value

Age 75, n (%)

76 (55.1)

72 (26.8)

< 0.001

Male, n (%)

70 (50.7)

150 (55.8)

0.334

Number of family doctors 2, n (%)

81 (58.7)

92 (34.2)

< 0.001

Feeling prescriptions were necessary, n (%)

111 (80.5)

195 (72.1)

0.079

Understanding reason for prescriptions, n (%)

125 (90.6)

252 (93.7)

0.257

Anxiety about reducing medicine, n (%)

66 (47.8)

165 (39.0)

0.089

Difficulty talking about reducing medicine, n (%)

34 (24.6)

33 (12.3)

0.001

  1. Univariate analyses showed significant differences between the polypharmacy group and the non-polypharmacy group in terms of the following 3 items: age, medical institutions visited for medical care, and the difficulty that patients had with asking their doctors to deprescribe their medications